ArticleHeliyon2024

Nomogram-based prognostic tool for stage IIIB/IV non-small cell lung cancer patients undergoing traditional Chinese medicine treatment.

Yihong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.